LDN193189isahighlypotentBMPinhibitor,preventsSmad1,Smad5,andSmad8phosphorylationthroughinhibitionofBMPtypeIreceptorsALK2(IC50=5nM)andALK3(IC50=30nM).ItsinhibitionsagainstALK4,ALK5,andALK7areweak(IC50>500nM).AsBMPsignalingcoordinatesdevelopmentalpatterningandhasessentialphysiologicalrolesinmatureorganisms,LDN-193189isusedtoreduceectopicossificationinamousemodel.
ProductCitation
Technicalinformation:
| ChemicalFormula: | C25H22N6C25H22N6 | |
| CAS#: | 1062368-24-4 | |
| MolecularWeight: | 406.48 | |
| Purity: | >98% | |
| Appearance: | Yellowsolid | |
| ChemicalName: | 4-(6-(4-(piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | |
| Solubility: | Upto100mMinDMSO |
ShippingCondition:Theproductisshippedinaglassvialatambienttemperature.
Storage:Forlongershelflife,storesolidpowderat4oCdesiccated,orstoreDMSOsolutionat-20oC.
Reference:
| 1. | PaulBYu,etal.BMPtypeIreceptorinhibitionreducesheterotopicossification.NatureMed.(2008)14:1363-1369. |
| 2. | CunyGD,etal.Structure-activityrelationshipstudyofbonemorphogeneticprotein(BMP)signalinginhibitors.BioorgMedChemLett.(2008)18(15):4388-92. |
| 3. | PaulBYu,etal.DorsomorphininhibitsBMPsignalsrequiredforembryogenesisandironmetabolism.NatureChemBiol.(2008)4:33-41. |